GILD - Gilead Sciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
22,357,000
22,127,000
26,107,000
30,390,000
32,639,000
Cost of Revenue
4,613,000
4,853,000
4,371,000
4,261,000
4,006,000
Gross Profit
17,744,000
17,274,000
21,736,000
26,129,000
28,633,000
Operating Expenses
Research Development
5,106,000
5,018,000
3,734,000
5,098,000
3,014,000
Selling General and Administrative
4,204,000
4,056,000
3,878,000
3,398,000
3,426,000
Total Operating Expenses
9,310,000
9,074,000
7,612,000
8,496,000
6,440,000
Operating Income or Loss
8,434,000
8,200,000
14,124,000
17,633,000
22,193,000
Interest Expense
1,023,000
1,077,000
1,118,000
964,000
688,000
Total Other Income/Expenses Net
1,029,000
676,000
523,000
428,000
154,000
Income Before Tax
8,440,000
7,799,000
13,529,000
17,097,000
21,659,000
Income Tax Expense
2,495,000
2,339,000
8,885,000
3,609,000
3,553,000
Income from Continuing Operations
5,945,000
5,460,000
4,644,000
13,488,000
18,106,000
Net Income
5,955,000
5,455,000
4,628,000
13,501,000
18,108,000
Net Income available to common shareholders
5,955,000
5,455,000
4,628,000
13,501,000
18,108,000
Reported EPS
Basic
-
4.20
3.54
10.08
12.37
Diluted
-
4.17
3.51
9.94
11.91
Weighted average shares outstanding
Basic
-
1,298,000
1,307,000
1,339,000
1,464,000
Diluted
-
1,308,000
1,319,000
1,358,000
1,521,000
EBITDA
-
8,876,000
14,647,000
18,061,000
22,347,000